Renato Zambello

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Jo Caers

BELGIUM

View details

Stefania Bortoluzzi

University of Padova

ITALY

View details

MICHELE CAVO

University of Bologna

ITALY

View details

Francesco Piazza

Assistant Professor of Hematology

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

SABRINA MANNI

Assistant Professor

University of Padua

ITALY

View details

Maria Teresa VOSO

Professore Ordinario di Ematologia

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Paolo de Fabritiis

University of Rome Tor Vergata

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Renato Zambello

Research Interests

Explore related searches

Contact this professor

Articles (14)

Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168

Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma

Belantamab mafodotin in triple‐refractory multiple myeloma patients: A retro‐prospective observational study in Italy

The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders

Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia

Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study

Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel

LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence

CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma

All that glitters is not LGL Leukemia

Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe

Interrogating molecular genetics to refine LGLL classification

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score

Collaborators (7)

Jo Caers

Stefania Bortoluzzi

MICHELE CAVO

Francesco Piazza

SABRINA MANNI

Maria Teresa VOSO

Paolo de Fabritiis

Make your next move.